CWA
TMO icon

Crux Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Crux Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Sell
893
-117
-12% -$56.2K 0.16% 127
2026
Q1 		$496K Buy
+1,010
New +$548K 0.19% 115

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Crux Wealth Advisors's TMO Position: Q2 2026 in Review

Crux Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $56.2K and leaving 893 shares worth $448K. The position accounts for 0.16% of the portfolio, ranked #127.

Crux Wealth Advisors first reported a position in TMO in Q1 2026 and has held it in 2 quarters since. The position peaked at $496K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Crux Wealth Advisors held 893 shares of Thermo Fisher Scientific worth $448K as of Q2 2026.
  • Crux Wealth Advisors sold 117 Thermo Fisher Scientific shares in Q2 2026, an estimated $56.2K.
  • Thermo Fisher Scientific made up 0.16% of Crux Wealth Advisors's portfolio in Q2 2026, its #127 holding.
  • Crux Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2026 and has held it in 2 quarters since.
  • Crux Wealth Advisors's Thermo Fisher Scientific position peaked at $496K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Crux Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.